The preclinical data generated by agents produced by the GLP practice can be valuable in the later development of clinical trials in gene therapy. To help investigators choose the optimum vector ...
“We have seen remarkable results from clinical trials using AAV vectors for AADC gene transfer,” says Shin-ichi Muramatsu, a pioneer of AAV vector research, and a professor in Jichi Medical ...
Earlier the sanitary watchdog who runs the Vector center reported that 86 volunteers would receive the vaccine during the second phase of clinical trials. Russia, like any other country ...
TASS/. Post-registration trials of a vaccine against the coronavirus developed by the Vector State Research Center of Virology and Biotechnology will begin in November-December, the press service ...
D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and ...
An inhalable version of a single-shot, adenovirus-based viral vector vaccine might provide ... completed a Phase III clinical trial of their intramuscular COVID-19 vaccine, which involved 45,000 ...
"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback